Skip to main content
Loading
Immanuel Lerner

Immanuel Lerner, PhD

CEO, Pepticom
Israel
Scientist and biotech entrepreneur with a proven track record in envisioning and establishing a successful AI/biotech startup. I co-invented, founded and leading Pepticom, a disruptive company in the field of AI-based peptide drug discovery/design. I led Pepticom from concept to revenue generation via collaboration with large multinational companies, negotiated and executed discovery deals and seed/Round A finance. My 15-year academic career prior to the establishment of Pepticom includes a Ph.D. in biochemistry followed by postdoctoral research at the Hebrew University of Jerusalem. During my studies, I published research in leading journals such as Blood, Nature Communications, the Journal of Clinical Investigation, Cancer Research, and others, and had the honor of publishing my postdoc research with the 2017 Nobel Laureate in Physiology/Medicine Prof. Michael Rosbash.

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS